ISZO CAPITAL MANAGEMENT LP - Q3 2021 holdings

$227 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 7 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 87.5% .

 Value Shares↓ Weighting
NTP BuyNAM TAI PPTY INC$136,975,000
-3.6%
5,891,377
+14.9%
60.43%
+17.1%
CDMO  AVID BIOSERVICES INC$50,624,000
-15.9%
2,346,9610.0%22.33%
+2.2%
LNDC NewLANDEC CORP$15,199,0001,648,520
+100.0%
6.70%
NOTV BuyINOTIV INC$9,478,000
+33.1%
324,129
+21.5%
4.18%
+61.7%
XPEL  XPEL INC$7,879,000
-9.6%
103,8600.0%3.48%
+9.9%
CCEL NewCRYO-CELL INTL INC$6,013,000496,503
+100.0%
2.65%
RENN NewRENREN INCsponsored ads$506,00036,384
+100.0%
0.22%
CHS ExitCHICOS FAS INC$0-20,690
-100.0%
-0.05%
PTGX ExitPROTAGONIST THERAPEUTICS INC$0-93,883
-100.0%
-1.53%
ATEX ExitANTERIX INC$0-126,311
-100.0%
-2.75%
ExitDERMTECH INC$0-1,090,254
-100.0%
-16.46%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NAM TAI PPTY INC16Q3 202260.5%
AVID BIOSERVICES INC13Q4 202146.6%
XPEL INC10Q4 202122.3%
TARO PHARMACEUTICALS INDUS LTD8Q4 201585.7%
AMERCO8Q4 201511.2%
NATHANS FAMOUS INC NEW7Q1 201768.9%
MMA CAP MGMT LLC7Q1 201717.8%
CBL & ASSOC PPTYS INC6Q3 202395.2%
LIFECORE BIOMEDICAL INC6Q4 202235.1%
CRYO-CELL INTL INC6Q4 202211.0%

View ISZO CAPITAL MANAGEMENT LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-12

View ISZO CAPITAL MANAGEMENT LP's complete filings history.

Compare quarters

Export ISZO CAPITAL MANAGEMENT LP's holdings